A case-control study revealed that metformin significantly lowered the risk of PDAC in diabetic patients, whereas the use of insulin or insulin secretagogues was linked to a higher PDAC risk in individuals with diabetes.417. This evidence concerns the gene INS and diabetes mellitus.